Atombeat Inc.
Atombeat democratizes computational drug discovery by giving researchers accessible AI- and physics-powered tools to speed discovery. Its Hermite platform and RiDYMO hit discovery leverage AI, physics-based modeling, Uni-FEP, Uni-VSW, RiD, AWS, and GPU acceleration for FEP calculations and virtual screening. The company offers SaaS subscriptions, computational FTE services, and fee-for-service drug discovery to drug research teams and organizations. It targets a broad market seeking faster hit identification, lead optimization, and new modalities like small molecules, peptides, and conjugates.
Atombeat Inc.
Atombeat democratizes computational drug discovery by giving researchers accessible AI- and physics-powered tools to speed discovery. Its Hermite platform and RiDYMO hit discovery leverage AI, physics-based modeling, Uni-FEP, Uni-VSW, RiD, AWS, and GPU acceleration for FEP calculations and virtual screening. The company offers SaaS subscriptions, computational FTE services, and fee-for-service drug discovery to drug research teams and organizations. It targets a broad market seeking faster hit identification, lead optimization, and new modalities like small molecules, peptides, and conjugates.